ALM Equity AB
STO:ALM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ALM Equity AB
STO:ALM
|
SE |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
FLSmidth & Co A/S
CSE:FLS
|
DK |
|
Pointerra Ltd
ASX:3DP
|
AU |
|
SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
|
IN |
|
H
|
Hyundai Ezwel Co Ltd
KOSDAQ:090850
|
KR |
|
D
|
DeFi Technologies Inc
NEO:DEFI
|
CA |
|
Dave Inc
NASDAQ:DAVE
|
US |
|
A
|
Ashok Alco-Chem Ltd
BSE:524594
|
IN |
|
Pembina Pipeline Corp
TSX:PPL
|
CA |
|
Central Asia Metals PLC
LSE:CAML
|
UK |
Wall Street
Price Targets
ALM Price Targets Summary
ALM Equity AB
According to Wall Street analysts, the average 1-year price target for ALM is 135.92 SEK with a low forecast of 90.9 SEK and a high forecast of 210 SEK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALM's stock price target?
Price Target
135.92
SEK
According to Wall Street analysts, the average 1-year price target for ALM is 135.92 SEK with a low forecast of 90.9 SEK and a high forecast of 210 SEK.
What is ALM Equity AB's Revenue forecast?
Projected CAGR
66%
For the last 14 years the compound annual growth rate for ALM Equity AB's revenue is 8%. The projected CAGR for the next 2 years is 66%.
